Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer-Reference-Cited by-同舟云学术

Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer

Published:2015-12 Issue:4 Volume:27 Page:205-215
ISSN:1110-0362
Container-title:Journal of the Egyptian National Cancer Institute
language:en
Short-container-title:Journal of the Egyptian National Cancer Institute

Author:

Arafat Waleed,Zhou Tong,Naoum George E.,Buchsbaum Donald J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference41 articles.

1. Society AC. Cancer facts and figures. Atlanta; 2004.

2. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. The American Urological Association;Middleton;J Urol,1995

3. Outcomes of external-beam radiation therapy for prostate cancer: a study of medicare beneficiaries in three surveillance, epidemiology, and end results areas;Fowler;J Clin Oncol,1996

4. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer;Zelefsky;Radiother Oncol,2000

5. Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?;Rosenberg;Clin Prostate Cancer,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics;Biochemical Pharmacology;2024-03

2. Potential of Gold Nanoparticles in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblasts;Cancers;2022-07-22

3. First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer;Journal for ImmunoTherapy of Cancer;2021-07

4. Atorvastatin Enhances Inhibitory Effects of Irradiation on Tumor Growth by Reducing MSH2 Expression both in Prostate Cancer Cells and Xenograft Tumor Models;Anti-Cancer Agents in Medicinal Chemistry;2021-06-02

5. FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells;Journal of Cancer Research and Therapeutics;2021